Is T1G3 bladder cancer having a definite muscle layer in TUR specimens a highly progressive disease?

Japanese Journal of Clinical Oncology

Volumn 40, Issue 2, 2010, Pages 153-156

  Shindo, Tetsuya ^a   Masumori, Naoya ^a   Fukuta, Fumimasa ^a   Miyamoto, Shintaro ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Muscle layer; Progression; T1G3; Understaging

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BCG VACCINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUSCLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TRANSURETHRAL RESECTION; BLADDER TUMOR; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; SMOOTH MUSCLE; UROLOGIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BCG VACCINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; RECURRENCE; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 77449114622     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp132     Document Type: Article

References (15)

1. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy. J Urol 2007;177:75.
2. Andius P, Holmang S. Bacillus Calmette Guerin therapy in Stage Ta/T1 bladder cancer: prognostic factor for time to recurrence and progression. BJU Int 2003;93:980.
3. Shahin O, Thalman GN, Rentsch C, Mazzuchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical BCG for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. JUrol2003;169:96.
4. Stockle M. Radical cystectomy-often too late? Eur Urol 1987;13:361.
5. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999;162:74.
6. Gohji K, Nomi M, Okamoto M, Takenaka A, Hara I, Okada H, et al. Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of bladder. Urology 1999;53:308.
7. Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001;166:490.
8. Bono AV, Benvenuti C, Damiano G, Lovisolo J. Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer. Urology 1994;44:329.
9. Serretta V, Piazza S, Pavone C, Piazza B, Pavone-Macaluso M. Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1G3 transitional cell carcinoma of the bladder. Urology 1996;47:647.
10. Hara I, Miyake H, Takechi Y, Eto H, Gotoh A, Fujisawa M, et al. Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder. Int J Urol 2003;10:19.
11. Han RF, Pan JG. Can intravesical bacillus Calmette Gurein reduce recurrence in patients with superficial bladder cancer? A meta analysis of randomized trials. Urology 2006;67:1216.
12. Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Intravesical bacillus Calmette Gurein is superior to mitomycin C in reducing tumor recurrence in high risk superficial bladder cancer: a meta analysis of randomized trials. BJU Int 2004;93:485.
13. Brake M, Loertzer H, Horsch R, Keller H. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000;163:169.
14. Patard J, Moudouni S, Saint F, Rioux-Leclercq N, Manunta A, Guy L, et al. Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology 2001;58:551.
15. Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006;175:1641.